SUGAMMADEX 100 mg /Ml Injectable Solution
Prescription review online
A doctor will review your case and decide whether a prescription is medically appropriate.
Talk to a doctor about this medicine
Discuss your symptoms and possible next steps in a quick online consultation.
How to use SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION
Contents of the leaflet
- Introduction
- What Sugammadex Fresenius Kabi is and what it is used for
- What you need to know before you are given Sugammadex Fresenius Kabi
- How Sugammadex Fresenius Kabi is given
- Possible side effects
- Storage of Sugammadex Fresenius Kabi
- Contents of the pack and other information
Introduction
Package Leaflet: Information for the User
Sugammadex Fresenius Kabi 100 mg/ml Solution for Injection
sugammadex
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your anaesthetist or doctor.
- If you get any side effects, talk to your anaesthetist or doctor. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack
- What Sugammadex Fresenius Kabi is and what it is used for
- What you need to know before you are given Sugammadex Fresenius Kabi
- How Sugammadex Fresenius Kabi is given
- Possible side effects
- Storage of Sugammadex Fresenius Kabi
- Contents of the pack and other information
1. What Sugammadex Fresenius Kabi is and what it is used for
What Sugammadex Fresenius Kabi is
Sugammadex Fresenius Kabi contains the active substance sugammadex. Sugammadex is considered a selective relaxant binding agentas it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
What Sugammadex Fresenius Kabi is used for
If you have to undergo surgery, your muscles must be completely relaxed, making it easier for the surgeon to perform the operation. For this, you will be given medicines during general anaesthesia to relax your muscles. These are called muscle relaxants, such as rocuronium bromide and vecuronium bromide. Since these medicines also block the respiratory muscles, you will need help breathing (artificial respiration) during and after surgery until you can breathe on your own again.
Sugammadex is used to speed up the recovery of your muscles after surgery so that you can breathe on your own again sooner. It does this by binding to rocuronium bromide or vecuronium bromide in your body. It can be used in adults when rocuronium bromide or vecuronium bromide is used.
It can be used in newborns, infants, children, and adolescents (from birth to 17 years) when rocuronium bromide is used.
Not sure if this medicine is right for you?
Discuss your symptoms and treatment with a doctor online.
2. What you need to know before you are given Sugammadex Fresenius Kabi
Do not receive Sugammadex Fresenius Kabi
- if you are allergic to sugammadex or any of the other ingredients of this medicine (listed in section 6).
Tell your anaesthetist if this applies to you.
Warnings and precautions
Consult your anaesthetist before you are given sugammadex
- if you have any kidney disease or have had it in the past. This is important because sugammadex is removed from your body by the kidneys.
- if you have any liver disease or have had it before.
- if you have fluid retention (oedema).
- if you have any disease that increases the risk of bleeding (blood coagulation disorders) or if you are taking anticoagulant medication.
Other medicines and Sugammadex Fresenius Kabi
Tell your anaesthetist if you are taking, have recently taken, or might take any other medicines.
Sugammadex may affect other medicines or be affected by them.
Some medicines reduce the effect of Sugammadex Fresenius Kabi
It is especially important that you tell your anaesthetist if you have taken any of the following recently:
- toremifene (used to treat breast cancer).
- fusidic acid (an antibiotic).
Sugammadex Fresenius Kabi may affect hormonal contraceptives
- Sugammadex Fresenius Kabi may make hormonal contraceptives - such as the "Pill", vaginal ring, implants, or an Intrauterine Hormonal Device (IUD) - less effective because it reduces the amount of progestogen that reaches you. The amount of progestogen lost due to the use of sugammadex is approximately the same as that lost when you miss a birth control pill.
→ If you are taking the Pillon the same day that you are given sugammadex, follow the instructions for a missed pill in the pill leaflet.
→ If you are using otherhormonal contraceptives (e.g. vaginal ring, implant, or IUD), you should use a non-hormonal contraceptive method (such as a condom) for the next 7 days and follow the recommendations in the leaflet.
Effects on blood tests
Generally, sugammadex does not affect laboratory tests. However, it may affect the results of a blood test when progesterone levels are measured. Consult your doctor if your progesterone levels need to be tested on the same day that you receive sugammadex.
Pregnancy and breast-feeding
Tell your anaesthetist if you are pregnant or think you may be pregnant or if you are breast-feeding. You may still be given sugammadex, but this needs to be discussed beforehand.
It is not known if sugammadex passes into breast milk. Your anaesthetist will help you decide whether to stop breast-feeding or avoid treatment with sugammadex, considering the benefit of breast-feeding to the baby and the benefit of sugammadex to the mother.
Driving and using machines
Sugammadex Fresenius Kabi has no known influence on the ability to drive and use machines.
Sugammadex Fresenius Kabi contains sodium
This medicine contains up to 9.7 mg of sodium (the main component of cooking/table salt) per ml. This is equivalent to 0.5% of the maximum daily intake of sodium recommended for an adult.
3. How Sugammadex Fresenius Kabi is given
Sugammadex Fresenius Kabi will be given to you by your anaesthetist, or under the supervision of your anaesthetist.
Dose
Your anaesthetist will calculate the dose of sugammadex that you need based on:
- your weight
- the amount of muscle relaxant that is still affecting you.
The usual dose is 2-4 mg per kg of body weight for patients of any age. A dose of 16 mg/kg may be used in adults if urgent recovery of muscle relaxation is needed.
How Sugammadex Fresenius Kabi is given
Sugammadex will be given to you by your anaesthetist. It is injected once into a vein.
If you are given more Sugammadex Fresenius Kabi than recommended
Since your anaesthetist will be carefully monitoring the situation, it is unlikely that you will be given too much sugammadex. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anaesthetist or doctor.
Started taking the medicine and have questions?
Discuss your symptoms and treatment with a doctor online.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If these side effects occur while you are under anaesthesia, it will be your anaesthetist who detects and treats them.
Common (may affect up to 1 in 10 people)
- Cough
- Respiratory difficulties that may include cough or movements as if waking up or taking a breath
- Light anaesthesia – you may start to wake up, so you may need more anaesthetic. This may cause you to move or cough at the end of the operation
- Complications during the procedure, such as changes in heart rate, cough, or movement
- Decrease in blood pressure due to surgery
Uncommon (may affect up to 1 in 100 people)
- Difficulty breathing due to muscle spasms in the airways (bronchospasm) that occur in patients with a history of lung problems
- Allergic reactions (hypersensitivity to the active substance) - such as rash, redness of the skin, swelling of your tongue and/or pharynx, difficulty breathing, changes in blood pressure or heart rate, which sometimes result in a severe drop in blood pressure. Allergic reactions or severe allergic reactions can be life-threatening
- Allergic reactions were reported more frequently in healthy conscious volunteers
- Reappearance of muscle relaxation after surgery
Frequency not known
- When sugammadex is administered, a significant slowing of the heart can occur, which can even lead to cardiac arrest
Reporting of side effects
If you experience any side effects, talk to your anaesthetist or doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Sugammadex Fresenius Kabi
Storage will be the responsibility of healthcare professionals.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label after “EXP”. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions. Do not freeze. Store the vial in the outer packaging to protect it from light. After opening and dilution, store at 2-8 ºC and use within 24 hours.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
What Sugammadex Fresenius Kabi contains
- The active substance is sugammadex.
Each ml of solution for injection contains sugammadex sodium equivalent to 100 mg of sugammadex.
Each 1 ml vial contains sugammadex sodium equivalent to 100 mg of sugammadex.
Each 2 ml vial contains sugammadex sodium equivalent to 200 mg of sugammadex.
Each 5 ml vial contains sugammadex sodium equivalent to 500 mg of sugammadex.
- The other ingredients are water for injections, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment). See section 2 “Sugammadex Fresenius Kabi contains sodium”.
Appearance and packaging
Sugammadex Fresenius Kabi is a clear, colourless to slightly yellowish solution for injection, free from visible particles. It is available in three different pack sizes containing 10 vials of 1 ml, 2 ml, or 5 ml of solution for injection.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Fresenius Kabi Deutschland GmbH
Else-Kröner-Straße 1,
61352 Bad Homburg v.d.Höhe
Germany
Manufacturer
Labesfal - Laboratórios Almiro, S.A.
Zona Industrial do Lagedo
3465-157 Santiago de Besteiros
Portugal
You can request more information about this medicine from the local representative of the Marketing Authorisation Holder.
Date of last revision of this leaflet
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
This information is intended only for healthcare professionals:
Sugammadex Fresenius Kabi can be injected using the same line as for an ongoing infusion with the following intravenous solutions: sodium chloride 9 mg/ml (0.9%), glucose 50 mg/ml (5%), sodium chloride 4.5 mg/ml (0.45%) and glucose 25 mg/ml (2.5%), Ringer’s lactate solution, Ringer’s solution and glucose 50 mg/ml (5%) in sodium chloride 9 mg/ml (0.9%).
The infusion line should be flushed properly (e.g. with sodium chloride 0.9% solution) between administration of Sugammadex Fresenius Kabi and other medicines.
Use in the paediatric population
For paediatric patients, Sugammadex Fresenius Kabi can be diluted using sodium chloride 9 mg/ml (0.9%) to a concentration of 10 mg/ml (see section 6.3).
Disposal of unused medicine and all materials that have come into contact with it should be done according to local regulations.
For detailed information, consult the Summary of Product Characteristics or the Package Leaflet of Sugammadex Fresenius Kabi.
.
- Country of registration
- Dosage formINJECTABLE, 100 mg/ml
- ATC codeV03AB35
- Active substance
- Prescription requiredYes
- Manufacturer
- CompositionHIDROXIDO DE SODIO (E 524) (c.s.p. ml mg)
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTIONDosage form: INJECTABLE, 100 mgActive substance: sugammadexManufacturer: Merck Sharp & Dohme B.V.Prescription requiredDosage form: INJECTABLE, 100 mgActive substance: sugammadexManufacturer: Merck Sharp & Dohme B.V.Prescription requiredDosage form: INJECTABLE, 100 mg/mlActive substance: sugammadexManufacturer: Accord Healthcare S.L.U.Prescription required
Online doctors for SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION
Discuss questions about SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION is sugammadex. This information helps identify medicines with the same composition but different brand names.
SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION is manufactured by Fresenius Kabi Deutschland Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy SUGAMMADEX FRESENIUS KABI 100 mg/ml INJECTABLE SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (sugammadex) include BRIDION 100 mg/mL INJECTABLE SOLUTION, BRIDION 100 mg/mL INJECTABLE SOLUTION, SUGAMMADEX ACCORD 100 mg/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
